Checkpoint Inhibitor-Induced Colitis-A Clinical Overview of Incidence, Prognostic Implications and Extension of Current Treatment Options.

Portenkirchner, Carmen; Kienle, Peter; Horisberger, Karoline

Portenkirchner, Carmen; Kienle, Peter; Horisberger, Karoline.

Afiliação

Portenkirchner C; Department of Surgery, Cantonal Hospital of Baden, 5404 Baden, Switzerland.
Kienle P; Department of Abdominal and Transplantation Surgery, University Hospital of Zurich, Rämistrasse 100, 8091 Zürich, Switzerland.
Horisberger K; Department of General and Visceral Surgery, Theresienkrankenhaus and St. Hedwig-Klinik GmbH, 68165 Mannheim, Germany.

Pharmaceuticals (Basel) ; 14(4)2021 Apr 16.

Article em En | MEDLINE | ID: mdl-33923423

Palavras-chave

IBD; colitis; fecal transplantation; ileostomy; immune checkpoint inhibitor; immune checkpoint inhibitor-induced colitis; irAE; resumption

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google